Krystal Biotech buy Cantor Fitzgerald
Start price
13.12.23
/
50%
€105.00
Target price
13.12.24
€166.84
Performance (%)
47.38%
End price
14.12.24
€154.75
Summary
This prediction ended on 14.12.24 with a price of €154.75. With a performance of 47.38% the BUY prediction by Cantor_Fitzgerald was a big success. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Krystal Biotech | -1.187% | -1.187% | 32.332% |
| iShares Core DAX® | -0,98 % | -4,72 % | 4,79 % |
| iShares Nasdaq 100 | 1,16 % | 1,88 % | 20,23 % |
| iShares Nikkei 225® | -1,59 % | -5,39 % | 31,35 % |
| iShares S&P 500 | -0,28 % | 0,33 % | 13,91 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target raised by analysts at Cantor Fitzgerald from $160.00 to $180.00. They now have an "overweight" rating on the stock.
Ratings data for KRYS provided by MarketBeat
In the thread Trading Krystal Biotech
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Cantor_Fitzgerald for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€178.75
20.02.25
20.02.25
€205.35
20.02.26
20.02.26
22.52%
21.02.26
21.02.26
Krystal Biotech
Start price
Target price
Perf. (%)
€103.00
07.11.23
07.11.23
€149.84
07.11.24
07.11.24
75.83%
08.11.24
08.11.24